MAVAG FUNDA®-Filter Systems for Pharmaceutical Applications

MAVAG AG are specialists in the design, manufacturing and engineering of FUNDA®-Filter systems. Highly regarded in both the pharmaceutical and chemicals industries, the FUNDA®-Filter can also be used in many other applications. The FUNDA®-Filter system has demonstrated its value and cost effectiveness in a variety of demanding filtration processes such as in multipurpose pharmaceutical applications, catalyst recovery, caustic soda, resins, precious metal processing, food and beverage, metal processing and many more.

Over 5,000 units have been installed worldwide, demonstrating how many customers are satisfied with the product’s performance. Our customers are key players within their industries. Recent deliveries include Bristol Myers Squibb, Degussa, Pfizer, Dow Chemical, ECI Elektro-Chemie GmbH, Cytec, Biochemie Kundl, Aarhus Olie, Alpharma and Novartis.


You can operate the FUNDA®-Filter from either a local or a central control system. Typical steps during a filtration cycle include:

  • Filter filling
  • Recirculation (pre-filtration)
  • Feeding forward (filtration)
  • Heel filtration
  • Cake washing
  • Cake drying
  • Cake discharge
  • CIP

Combining the solid-liquid separation with the need for solid-liquid extraction, solids washing, product recovery and drying allows the FUNDA® system to perform to its peak. The FUNDA®-Filter system allows for filtration down to the last drop. A small quantity of washing liquid is all that is needed to wash the cake.

The proven design has been modified and optimised over the years and developed into a sterile filtration system. The FDA recently validated the FUNDA®-Filter for blood plasma filtration.


The filter cake is protected from falling off during pressure fluctuations because the build-up of filter cake takes place on the upper side of the conical filter leafs. Uniform solids distribution is achieved thanks to the stable build-up of the cake, meaning the washing and drying cycles show excellent results.


The FUNDA® has the following unique features:

  • Conical filter leafs
  • Conical bottom outlet
  • Top mounted drive

The result is a cake wash with a small amount of washing liquid and a highly efficient heel filtration "down to the last drop". Costs are reduced and profits maximised as, in comparison with other filters, the FUNDA®-systems provides greater returns.


The complete filtration cycle from filling to cake discharge and CIP are performed in a completely enclosed system. With appropriate packing systems, even the cake discharge takes place into a blanketed atmosphere. This makes the FUNDA®-Filter the separation technology of choice for hazardous or valuable products. It both protects the environment from emissions as well as the product from contamination.


Stainless steel, Hastelloy, Titan, rubber and Halar® E-CTFE linings are some of the materials involved in the manufacturing process. For the pressure vessel, ASME, PED and other design codes can be applied. The extreme longevity of the system and our high manufacturing standards are guaranteed. The average life of a system is 25 to 30 years.


Engineering contractors and end-users are assured the correct design of the filtration process by the experienced engineering support of MAVAG. The engineering of complete filtration plants, often skid-mounted systems, can be performed by MAVAG.


MAVAG AG’s after-sales support has a very good reputation. Delivering spare parts and re-engineering existing FUNDA®-Filter systems to accommodate a larger filtration area are just two of the services we can offer. Often, modifications to existing plants offer an excellent alternative. We can assist our clients with reactivating, refurbishing and up-grading existing units as we have archived documentation of all the filters delivered during the last 40 years.

For more information on the FUNDA®-Filter system and our company, please visit our website.

Make an enquiry


Kleiner Letten 9

CH-8213 Neunkirch



+41 52 687 02 02 +41 52 687 02 20

MAVAG Images

Products and Services


White Papers

Related Projects

Bristol Myers Squibb East Syracuse Pharmaceutical Manufacturing Facility

The Bristol Myers Squibb East Syracuse campus is more than 60 years old. Launched in 1943, the pharmaceutical manufacturing facility made nearly 70% of the penicillin produced in the world until the mid-2000s.

30 September 2013

Lonza Biotec

Lonza Biotec completed the construction of new manufacturing capacity with a multi-product design at Visp in Switzerland

28 September 2003

Richter Gedeon Hormone Production Facility

Richter Gedeon Vegyeszeti Gyar Rt, a well-known Hungarian pharmaceutical company, opened a new hormone production facili

5 March 2002

Boehringer Ingelheim Active Ingredients Plant

Boehringer Ingelheim officially opened the new active ingredients plant in Ingelheim in early 2003. The plant will be ab

4 March 2002

Novartis Diovan Manufacturing Plant, Schweizerhalle, Switzerland

In September 1999 Novartis opened a new pharmaceutical production facility at the Schweizerhalle site near Basel, Switzerland.

3 March 2002

Rohner Custom Synthesis Plant

In March 1999 Rohner AG began the construction of a new state-of-the-art pharmaceutical facility at its existing site at

Novartis’ API Plant in Grimsby, West Yorkshire, UK

Novartis Pharmaceuticals' active pharmaceutical ingredients (API) plant complex in Grimsby, West Yorkshire, was first established in 1951.

5 September 2001

Boehringer Ingelheim Biotechnology Process Plant, Biberach, Germany

In 2000, biotechnology company Boehringer Ingelheim awarded Stuttgart company Life Science Meissner & Wurst an engineering contract for the expansion of its Biberach plant.

12 February 2001

Press Release

Regional Offices


Kleiner Letten 9

CH-8213 Neunkirch



+41 52 687 02 02 +41 52 687 02 20

Go Top